Skip to main content
UCB logo

UCB — Investor Relations & Filings

Ticker · UCB ISIN · BE0003739530 LEI · 2138008J191VLSGY5A09 BR Manufacturing
Open in API
Filings indexed 2,018 across all filing types
Latest filing 2021-03-26 AGM Information
Country BE Belgium
Listing BR UCB

About UCB

https://www.ucb.com/

UCB is a global biopharmaceutical company that focuses on creating solutions for people living with severe diseases, primarily in the fields of neurology and immunology. The company's core activities include the research, development, and commercialization of pharmaceutical and biotechnology products. Guided by a patient-centric and science-driven approach, UCB is committed to innovation and sustainability. Through its UCB Ventures arm, it invests in pioneering technologies and companies with the potential to transform patient care. The company also offers personalized support services to patients and healthcare professionals during their treatment journey with a UCB medicine.

Recent filings

Filing Released Lang Actions
1. Convening notice AGM 29 avril 2021 - NL - (finaal) - 23.03.2021.wbk.pdf
AGM Information Classification · 1% confidence The document is explicitly titled 'OPROEPING TOT DE ALGEMENE VERGADERING VAN AANDEELHOUDERS' (Call for the General Meeting of Shareholders). It details the agenda items for a meeting scheduled for April 29, 2021, including voting on the annual accounts, remuneration reports, and crucially, the appointment and renewal of mandates for directors (Agenda Item 9). This content is characteristic of the materials distributed to shareholders in advance of an Annual General Meeting (AGM) to inform their voting decisions. This aligns perfectly with the definition of AGM Information (AGM-R). Although it discusses remuneration (which could relate to DEF 14A), the primary context and structure are that of the AGM notice itself.
2021-03-26 Dutch
20210319 - Acquisitions and Disposals of own shares.pdf
Transaction in Own Shares Classification · 1% confidence The document explicitly details the 'Acquisitions of own shares' and 'Disposal of own shares' by UCB SA/NV within a specific date range (March 12 to March 18, 2021) as part of its Share Repurchase Program 2021. This activity directly corresponds to the definition of a company buying back or selling its own shares, which maps precisely to the 'Transaction in Own Shares' category (POS). The document is a formal disclosure, not a general announcement of a report (RPA) or a broad regulatory filing (RNS).
2021-03-19 English
20210319 - Rachat et Aliénation d'actions propres.pdf
Transaction in Own Shares Classification · 1% confidence The document is titled "Rachat d'actions propres et aliénation d'actions propres" (Share repurchase and disposal of own shares) and details specific transactions (buybacks and disposals) of UCB's own shares between March 12 and March 18, 2021. This activity directly relates to the company managing its own stock capital, specifically share repurchases (buybacks) and subsequent transactions related to employee stock plans. This aligns perfectly with the definition of 'Transaction in Own Shares' (Code: POS), which covers share repurchase/issuance activities. It is not a general financing update (CAP) or a major shareholding notification (MRQ) which usually concerns external shareholders crossing thresholds.
2021-03-19 French
20210319 - Verwerving en vervreemding van eigen aandelen.pdf
Transaction in Own Shares Classification · 1% confidence The document is titled "Verwerving en vervreemding van eigen aandelen" (Acquisition and disposal of own shares) and details transactions where UCB NV bought back its own shares (share repurchase) and disposed of shares related to employee incentive plans. This directly corresponds to the definition of 'Transaction in Own Shares'. The document is a formal announcement ('gereglementeerde informatie') detailing specific dates, quantities, and prices of these transactions. This aligns perfectly with the 'Transaction in Own Shares' category (POS). It is not a general earnings release (ER), a full annual report (10-K), or a general regulatory filing (RNS), as it concerns a very specific corporate action.
2021-03-19 Dutch
20210312 - Acquisitions and Disposals of own shares.pdf
Transaction in Own Shares Classification · 1% confidence The document explicitly details the 'Acquisitions of own shares' and 'Disposal of own shares' conducted by UCB SA/NV under its Share Repurchase Program 2021, referencing specific dates, quantities, and prices. This activity directly corresponds to the definition of a company buying back or selling its own shares. Therefore, the appropriate filing type is 'Transaction in Own Shares' (POS). The document length is relatively short (3309 chars) and is a direct disclosure, not an announcement of a separate report.
2021-03-12 English
20210312 - Rachat et Aliénation d'actions propres.pdf
Transaction in Own Shares Classification · 1% confidence The document is titled "Rachat d'actions propres et aliénation d'actions propres" (Share repurchase and disposal of own shares) and details specific transactions where UCB bought back its own shares on Euronext Brussels between March 8 and March 11, 2021, and also disposed of shares related to employee stock options. This activity directly corresponds to the definition of a company reporting transactions involving its own shares, which is classified as 'Transaction in Own Shares' (POS). The document length is relatively short (3473 chars) and serves as a direct regulatory disclosure of these specific transactions, not an announcement of a larger report.
2021-03-12 French

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.